JY
TARA icon

Jeff Yass’s Protara Therapeutics TARA Stock Holding History

Jeff Yass’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.5K Sell
22,900
-6,100
-21% -$29K ﹤0.01% 12585
2026
Q1 		$151K Buy
29,000
+15,400
+113% +$91.1K ﹤0.01% 11992
2025
Q4 		$72.5K Buy
+13,600
New +$75.6K ﹤0.01% 11611
2025
Q3 		– Sell
-23,900
Closed -$72.4K – 13843
2025
Q2 		$72.4K Sell
23,900
-80,100
-77% -$276K ﹤0.01% 11966
2025
Q1 		$443K Sell
104,000
-3,800
-4% -$17K ﹤0.01% 9160
2024
Q4 		$569K Buy
+107,800
New +$348K ﹤0.01% 8353

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Jeff Yass's TARA Position: Q2 2026 in Review

Jeff Yass reduced its Protara Therapeutics (TARA) stake by 65% in Q2 2026, selling an estimated $363K and leaving 40,380 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #12185.

Jeff Yass first reported a position in TARA in Q1 2017 and has held it in 22 quarters since. The position peaked at $1.17M in Q1 2025. 118 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Jeff Yass held 40,380 shares of Protara Therapeutics worth $154K as of Q2 2026.
  • Jeff Yass sold 76,246 Protara Therapeutics shares in Q2 2026, an estimated $363K.
  • Protara Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12185 holding.
  • Jeff Yass first reported a position in Protara Therapeutics in Q1 2017 and has held it in 22 quarters since.
  • Jeff Yass's Protara Therapeutics position peaked at $1.17M in Q1 2025.
  • 118 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.